Outcome of ECMO and CRRT.

Mortality Clinical Trial

Official title:

Outcome of ECMO and CRRT, Experience of Hospital University MED VI, Oujda, Morocco.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05033509
• Other study ID #: Unite care
• Status: Completed
• Start date: January 1, 2019
• Est. completion date: December 31, 2020

Study information

• Verified date: August 2021
• Source: Mohammed VI University Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Background:

Although acute kidney injury (AKI) is a frequent complication in patients receiving extracorporeal membrane oxygenation (ECMO), and the CRRT impact is widely studied. The incidence of simultaneous use of ECMO and CRRT remain unclear.

Objective: The investigatore conducted this retrospective study to define the incidence of concomitant CRRT with ECMO therapy and to determine the overall impact of this strategy on patient outcomes such as mortality and renal recovery.

Methods:

The investigatore retrospectively analyzed data of patients of all ages, genders and ethnicities, admitted in the intensive care unit of Mohammed VI University Hospital, Oujda, Morocco, on a cumulative period of 2 years (January 2019 - December 2020). Were enrolled in the study patients who benefited from ECMO, and presented an acute kidney injury afterwards, using 'Microsoft Excel' as a software to utilize the information collected from the computerized patient database. 30 patients were included in the final study.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 30
• Est. completion date: December 31, 2020
• Est. primary completion date: December 31, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• benefited from ECMO .

• presented an acute kidney injury afterwards

Exclusion Criteria:

• patients who developed AKI before benefitting from ECMO and/or missing data

Related Conditions & MeSH terms

• Mortality

Intervention

Other:
• supervision the Kidney fonction on ECMO
patients who benefited from ECMO, and presented an acute kidney injury afterwards

Locations

Country	Name	City	State
Morocco	younes Oujidi	Berkane

Sponsors (1)

Lead Sponsor	Collaborator
Mohammed VI University Hospital

Country where clinical trial is conducted

Morocco, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Ecmo and severe AKI requiring CRRT	2 groups of patient was identified on this study : first ones are how developped aki and needek CRRT , 2nd are those who developped aki without CRRT	through study completion, an average of 24 mounths